Trivalent Influenza Vaccine (Split Virion, BK-01 Adjuvant) (Changchun Baike)

三价流感病毒裂解疫苗（BK-01佐剂）（长春百克）

Report date: 2025/10/14 14:51:15

Base Information

Drug NameTrivalent Influenza Vaccine (Split Virion, BK-01 Adjuvant) (Changchun Baike)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccineVaccines > Biological material > Viral vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesChangchun Bcht Biotechnology Co

China Registration ClassN/A

Develop Information

Active CompaniesChangchun Bcht Biotechnology Co

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A